Clinical Trials Logo

Disease Progression clinical trials

View clinical trials related to Disease Progression.

Filter by:

NCT ID: NCT02234440 Completed - Clinical trials for NASH Related Cirrhosis

Effect of Metformin on Disease Progression in Patients With Cryptogenic Cirrhosis (NASH-related Cirrhosis) With Diabetes or Impaired Glucose Tolerance or Insulin Resistance

Start date: September 1, 2014
Phase: N/A
Study type: Interventional

In this study, consecutive patients with cryptogenic cirrhosis (NASH-related cirrhosis), coming to ILBS (Institute of Liver & Biliary Sciences) OPD (Out patient Department) or getting admitted in the ward will be enrolled on fulfillment of inclusion/exclusion criteria and consent of the patient. These patients will be randomised to either metformin arm or conventional treatment arm. After enrollment these subjects will be monitored every three monthly for total of 12 months or till the primary endpoint is achieved. At the end of the study, outcome will be measured appropriately.

NCT ID: NCT02221427 Active, not recruiting - Labour Dystocia Clinical Trials

The Labour Progression Study, a Cluster Randomised Trial on Labour Progression for First Time Mothers

LAPS
Start date: December 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate if the rate of emergency caesarean section can be reduced if adhering to a dynamic labour progression curve compared to a static progression curve for first time mothers without jeopardising maternal and neonatal outcomes

NCT ID: NCT02206503 Completed - Multiple Myeloma Clinical Trials

Cyclophosphamide With Biochemical Progression During Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma (MM)

Start date: March 2013
Phase: Phase 2
Study type: Interventional

This study evaluates the efficacy of the addiction of Cyclophosphamide to Revlimid-low dose dexamethasone (Rd) in relapsed/refractory Multiple Myeloma patients, who experienced a biochemical progression, without CRAB, during Rd treatment.

NCT ID: NCT02186184 Completed - Myopia Clinical Trials

Effect of Orthokeratology Versus Spectacles on Myopia Progression in Chinese Children: A Crossover Trial

Start date: June 2014
Phase: Phase 4
Study type: Interventional

Orthokeratology is becoming popular for the treatment of myopia children. Many studies have shown that orthokeratology is effective in temporarily reducing refractive error, and is also helpful for controlling myopia progression. However, the mechanism for its slowing myopia progression and rebound effect after the treatment have not been clearly studied. In addition, the effect of orthokeratology among Chinese children has not been evaluated with randomized controlled trial.This study is to assess the effect of orthokeratology versus spectacles on myopia progression in school-aged Chinese children during two years.

NCT ID: NCT02182622 Withdrawn - Prostate Cancer Clinical Trials

LDE225 + Docetaxel/Prednisone for Adv/Met Castrate Resistant Prostate Cancer w/ Disease Progression After Docetaxel

Start date: July 2014
Phase: Phase 1
Study type: Interventional

The purpose of this study is to first determine the highest dose of LDE225 combined wtih Docetaxel and Prednisone that can be given that does not cause unacceptable side effects when given to patients with castrate resistant prostate cancer who failed previous docetaxel therapy.

NCT ID: NCT02176018 Completed - Episodic Migraine Clinical Trials

Nuedexta for the Prevention and Modification of Disease Progression in Episodic Migraine

Start date: August 2014
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and effectiveness of daily dextromethorphan/quinidine (Nuedexta) in reducing the frequency and progression of episodic migraine.

NCT ID: NCT02159612 Completed - Clinical trials for FSHD - Facioscapulohumeral Muscular Dystrophy

1 Year MRI Followup in Facioscapulohumeral Muscular Dystrophy

FSHD
Start date: May 2014
Phase: N/A
Study type: Observational

An investigation of disease progression in adult danish patients with facioscapulohumeral muscular dystrophy. The disease progression is followed for a year with two test-days, including functional muscle tests and a MRI scan of muscles in the back and legs.

NCT ID: NCT02152748 Active, not recruiting - Brain Tumor Clinical Trials

Disease Progression and Treatment-induced Alterations in Glioblastoma

Start date: April 2014
Phase: N/A
Study type: Observational

Summary of scientific evidence and rationale of this project: Integrative molecular-genetic approaches have provided important insights in the biology of glioblastoma. It has meanwhile become clear, that glioblastoma is not a single tumor entity but comprises different molecular subtypes, which are associated with a distinct genetic/epigenetic signature and prognosis. Multimodal treatment approaches combining radio- and chemotherapy as well as the recent introduction of novel antiangiogenic agents have resulted in increasing survival times and improved quality-of-life of glioblastoma patients. Yet, despite these intense treatment efforts the therapeutic efficacy in glioblastoma patients is limited, leading in virtually all cases to tumor recurrence and death of the patients. As only a limited fraction of glioblastoma patients undergo second neurosurgery at tumor recurrence (< 10%), post-therapeutic samples are rare and no systematic, large-scale studies exist, which address post-therapeutic morphological and molecular alterations in glioblastoma tumor tissue. Yet, these data would help to improve the understanding of mechanisms involved in therapy-resistance and tumor progression, to develop new therapeutic approaches and could pave the way for personalized treatment strategies.

NCT ID: NCT02137707 Completed - Clinical trials for Multiple Sclerosis-Relapsing-Remitting

Biologic Basis for Multiple Sclerosis Disease Progression in RRMS Patients Treated With Gilenya

IGLOO
Start date: November 2012
Phase:
Study type: Observational

This study will determine whether in RRMS patients receiving Gilenya there is a link between disease progression and biologic markers.

NCT ID: NCT02134652 Withdrawn - Dengue Clinical Trials

Ability of Bedside Ultrasound to Predict Progression of Severity of Disease in Dengue Fever

Start date: January 2015
Phase: N/A
Study type: Observational

The purpose of this study is determine the ability of bedide ultrasound performed in the Emergency Department and Outpatient Department can predict the severity of disease during a Dengue Fever outbreak in children, in Siem Reap, Cambodia. Our hypothesis is that the presence of gallbladder wall thickening and/or pleural effusions in children correlates with progression to Dengue hemorrhagic fever and Dengue shock. In addition, we hypothesize that sonographic imaging of pediatric patients presenting to the emergency department with a fever during a Dengue fever outbreak will change management and disposition.